Marizyme Inc - ESG Rating & Company Profile powered by AI
This Disclosure score includes seventeen UN Sustainable Development Goals including: 'No Poverty', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'. Alternative companies in the rating peer group for Marizyme Inc are displayed. The SDG assessment for Marizyme Inc indicates its transparency towards the United Nations Sustainable Development Goals.
Marizyme Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 2.0, social score of 2.0 and governance score of 4.0.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1393 | Vaccinex Inc | 2.8 | Medium |
| 1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
| 1437 | Marizyme Inc | 2.7 | Medium |
| 1437 | CanadaBis Capital Inc | 2.7 | Medium |
| 1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Marizyme Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Marizyme Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Marizyme Inc report the average age of the workforce?
Sign up for free to unlockDoes Marizyme Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Marizyme Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Marizyme Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Marizyme Inc offer flexible work?
Sign up for free to unlockDoes Marizyme Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Marizyme Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Marizyme Inc conduct supply chain audits?
Sign up for free to unlockDoes Marizyme Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Marizyme Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Marizyme Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Marizyme Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Marizyme Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Marizyme Inc disclose water use targets?
Sign up for free to unlockDoes Marizyme Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Marizyme Inc have a product recall in the last two years?
Sign up for free to unlockDoes Marizyme Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Marizyme Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Marizyme Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Marizyme Inc disclose parental leave metrics?
Sign up for free to unlockDoes Marizyme Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Marizyme Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Marizyme Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Marizyme Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Marizyme Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Marizyme Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Marizyme Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Marizyme Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Marizyme Inc disclose its waste policy?
Sign up for free to unlockDoes Marizyme Inc report according to TCFD requirements?
Sign up for free to unlockDoes Marizyme Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Marizyme Inc disclose energy use targets?
Sign up for free to unlockDoes Marizyme Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Marizyme Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Marizyme Inc
These potential risks are based on the size, segment and geographies of the company.
Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and burns, acute ischemic stroke, deep vein thrombosis, and dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and other indications. Further, it is involved in developing MATLOC, a point-of-care, lab-on-chip digital screening and diagnostic device platform for chronic kidney disease assessment. The company was formerly known as GBS Enterprises Incorporated. Marizyme, Inc. was incorporated in 2007 and is based in Jupiter, Florida.